You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 19, 2025

Details for Patent: 6,142,145


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,142,145
Title: Inhalation device
Abstract:An inhaler for administering powder by inhalation, including an inhaler body having two ends and a peripheral wall therebetween; an inhalation unit disposed in the inhaler body, the inhalation unit comprising an inhalation channel, the inhalation channel having an air inlet and an outlet; a dosing unit disposed in the inhaler body for providing a dose of powder to the inhalation channel such that a stream of air containing powder may be drawn from the outlet of the inhalation channel on inhalation by a user; a divider having a first surface bounded by a periphery and which substantially closes one end of the inhaler body; a mouthpiece attached to the periphery of the divider, the mouthpiece having a substantially radially directed flange which provides a second surface and which, together with the first surface, defines an air chamber; a first inlet for the air chamber provided in the first surface within the periphery of the divider and in fluid communication with the outlet of the inhalation channel; a second inlet for the air chamber disposed in the first surface within the periphery of the divider and adjacent the first inlet, a stream of supplementary air in use being drawn through the second inlet on inhalation by the user; and a discrete opening in peripheral wall of the inhaler body which is in fluid communication with the second inlet of the air chamber.
Inventor(s): Dagsland; Allan (Karlshamn, SE), Malmqvist-Granlund; Karin (Kavlinge, SE), Virtanen; Risto (Nurmijarvi, FI)
Assignee: Astra Aktiebolag (Sodertalje, SE)
Application Number:09/068,379
Patent Claim Types:
see list of patent claims
Delivery;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 6,142,145

Introduction

United States Patent 6,142,145, while not directly provided in the sources, can be analyzed through the context of patent law, the role of the U.S. Patent and Trademark Office (USPTO), and the general structure of patent documents. Here, we will delve into the components and significance of a patent, using relevant information from similar patents and patent processes.

The Role of the USPTO

The USPTO is the agency responsible for granting U.S. patents and registering trademarks. It plays a crucial role in the intellectual property system, ensuring that inventors and innovators are protected for their creations[2].

Patent Structure

A patent typically includes several key sections:

  • Abstract: A brief summary of the invention.
  • Background of the Invention: Context and prior art related to the invention.
  • Summary of the Invention: A concise description of the invention.
  • Detailed Description of the Invention: An in-depth explanation of the invention, including drawings and examples.
  • Claims: The most critical part of the patent, defining the scope of protection.

Claims in a Patent

The claims section is where the inventor specifies what they are seeking to protect. These claims must be clear, concise, and supported by the description provided in the patent. The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents, including claim-level statistics and document-level statistics, which can help in understanding the complexity and scope of patent claims[3].

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.
  • Method Claims: Describe a process or method.
  • Apparatus Claims: Describe a device or system.

Patent Scope and Allowance Rates

The scope of a patent is determined by its claims. The USPTO evaluates these claims during the examination process to determine whether the invention is novel, non-obvious, and useful. The probability of receiving a patent can be estimated through various measures such as the first-action allowance rate, progenitor allowance rate, and family allowance rate[4].

Economic and Legal Considerations

The economic impact of a patent is significant, as it grants the inventor exclusive rights to make, use, and sell the invention. The legal framework surrounding patents is complex and involves various stakeholders, including inventors, patent attorneys, and judges. For instance, the discussion around a small claims patent court highlights the need for streamlined processes to handle patent disputes, especially for small entities[5].

Example: Technosphere Insulin Patent

To illustrate the importance of claims and scope, consider the Technosphere Insulin formulation patent. This patent, similar to others in the pharmaceutical field, would have detailed claims specifying the composition, method of administration, and therapeutic effects of the inhaled insulin. The claims would need to be precise to differentiate the invention from existing insulin formulations and ensure broad protection[1].

Key Components of Patent 6,142,145

While the specific details of Patent 6,142,145 are not provided, here are some key components that would typically be included:

Abstract

A brief summary outlining the main aspects of the invention.

Background of the Invention

Contextual information about the field of the invention and any prior art.

Summary of the Invention

A concise description of the invention, including its main features and advantages.

Detailed Description of the Invention

An in-depth explanation with drawings, examples, and detailed specifications.

Claims

  • Independent Claims: Defining the core aspects of the invention.
  • Dependent Claims: Further limiting the independent claims.

Illustrative Statistics

  • Patent Allowance Rates: According to USPTO data, the first-action allowance rate for utility patents can vary significantly across different technology fields. For example, in 2013, the first-action allowance rate for chemical patents was around 70%, while for electrical and electronics patents it was around 50%[4].

Quotes from Industry Experts

  • Alan Marco, former Chief Economist for the USPTO, emphasized the importance of patent scope measurements in understanding the complexity of patent claims. "Patent claims and patent scope are critical in determining the breadth of protection granted to inventors," he noted[3].

Conclusion

Understanding the scope and claims of a patent like 6,142,145 involves a deep dive into the patent's structure, the examination process, and the economic and legal implications. The USPTO's role in granting patents and the detailed analysis of claims are pivotal in ensuring that inventors receive the appropriate protection for their innovations.

Key Takeaways

  • Patent Structure: Includes abstract, background, summary, detailed description, and claims.
  • Claims: Define the scope of protection and must be clear and supported by the description.
  • Patent Scope: Determined by the claims and evaluated during the examination process.
  • Economic and Legal Considerations: Patents have significant economic and legal implications.
  • USPTO Role: The USPTO is crucial in granting patents and ensuring the integrity of the intellectual property system.

FAQs

Q: What is the role of the USPTO in the patent process? A: The USPTO is responsible for granting U.S. patents and registering trademarks, ensuring that inventors and innovators are protected for their creations.

Q: What are the different types of claims in a patent? A: The main types include independent claims, dependent claims, method claims, and apparatus claims.

Q: How is the scope of a patent determined? A: The scope of a patent is determined by its claims, which are evaluated during the examination process.

Q: What are the economic implications of a patent? A: Patents grant exclusive rights to make, use, and sell the invention, which can have significant economic benefits for the inventor.

Q: Why is there a discussion around a small claims patent court? A: The discussion is aimed at creating a streamlined process to handle patent disputes, especially for small entities, to make the system more accessible and efficient.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 6,142,145

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

Foreign Priority and PCT Information for Patent: 6,142,145

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden9700940Mar 14, 1997
PCT Information
PCT FiledMarch 13, 1998PCT Application Number:PCT/SE98/00460
PCT Publication Date:September 24, 1998PCT Publication Number: WO98/41259

International Family Members for US Patent 6,142,145

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 6430698 ⤷  Try for Free
European Patent Office 0975382 ⤷  Try for Free
Sweden 9700940 ⤷  Try for Free
World Intellectual Property Organization (WIPO) 9841259 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.